1. Home
  2. WAL vs CORT Comparison

WAL vs CORT Comparison

Compare WAL & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAL
  • CORT
  • Stock Information
  • Founded
  • WAL 1994
  • CORT 1998
  • Country
  • WAL United States
  • CORT United States
  • Employees
  • WAL N/A
  • CORT N/A
  • Industry
  • WAL Major Banks
  • CORT Biotechnology: Pharmaceutical Preparations
  • Sector
  • WAL Finance
  • CORT Health Care
  • Exchange
  • WAL Nasdaq
  • CORT Nasdaq
  • Market Cap
  • WAL 9.3B
  • CORT 7.1B
  • IPO Year
  • WAL 2005
  • CORT N/A
  • Fundamental
  • Price
  • WAL $74.90
  • CORT $54.99
  • Analyst Decision
  • WAL Strong Buy
  • CORT Strong Buy
  • Analyst Count
  • WAL 15
  • CORT 4
  • Target Price
  • WAL $98.07
  • CORT $99.75
  • AVG Volume (30 Days)
  • WAL 1.2M
  • CORT 1.3M
  • Earning Date
  • WAL 04-17-2025
  • CORT 04-30-2025
  • Dividend Yield
  • WAL 1.97%
  • CORT N/A
  • EPS Growth
  • WAL 8.41
  • CORT 30.85
  • EPS
  • WAL 7.09
  • CORT 1.23
  • Revenue
  • WAL $3,016,200,000.00
  • CORT $675,040,000.00
  • Revenue This Year
  • WAL $13.49
  • CORT $36.81
  • Revenue Next Year
  • WAL $10.02
  • CORT $29.94
  • P/E Ratio
  • WAL $10.87
  • CORT $44.72
  • Revenue Growth
  • WAL 17.96
  • CORT 39.94
  • 52 Week Low
  • WAL $53.75
  • CORT $20.84
  • 52 Week High
  • WAL $98.10
  • CORT $75.00
  • Technical
  • Relative Strength Index (RSI)
  • WAL 34.74
  • CORT 36.77
  • Support Level
  • WAL $71.58
  • CORT $52.45
  • Resistance Level
  • WAL $87.68
  • CORT $61.39
  • Average True Range (ATR)
  • WAL 3.35
  • CORT 3.27
  • MACD
  • WAL -1.31
  • CORT -1.06
  • Stochastic Oscillator
  • WAL 22.27
  • CORT 18.18

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

Share on Social Networks: